{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:36:55Z","timestamp":1717454215248},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute of Maternal and Child Health IRCCS \u201cBurlo Garofolo\u201d","award":["RC 13\/08"],"award-info":[{"award-number":["RC 13\/08"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.phrs.2010.02.012","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T15:22:47Z","timestamp":1267716167000},"page":"506-510","source":"Crossref","is-referenced-by-count":13,"title":["Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches"],"prefix":"10.1016","volume":"61","author":[{"given":"Luigina","family":"De Leo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Marcuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Tommasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Crovella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Pontillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2010.02.012_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.phrs.2010.02.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj1990001","article-title":"The contribution of the cholesterol biosynthetic pathway to intermediary metabolism and cell function","volume":"199","author":"Fears","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2010.02.012_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.157.1.400","article-title":"Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells","volume":"157","author":"Drenth","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.phrs.2010.02.012_bib4","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","article-title":"Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome","volume":"46","author":"Frenkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.phrs.2010.02.012_bib5","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.phrs.2010.02.012_bib6","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.molimm.2007.12.008","article-title":"Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1","volume":"45","author":"Kuijk","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.phrs.2010.02.012_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2008.07099.x","article-title":"Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia","volume":"141","author":"Braun","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.phrs.2010.02.012_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1006\/bbrc.1999.1546","article-title":"Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells","volume":"264","author":"Kouchi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2010.02.012_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1203\/PDR.0b013e3181761870","article-title":"Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency","volume":"64","author":"Marcuzzi","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.phrs.2010.02.012_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.095976","article-title":"Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib","volume":"317","author":"Xue","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2010.02.012_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1006\/bbrc.1995.1854","article-title":"Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells","volume":"211","author":"Crick","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2010.02.012_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1388-1981(00)00135-9","article-title":"Biochemical and genetic aspects of mevalonate kinase and its deficiency","volume":"1529","author":"Houten","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2010.02.012_bib13","doi-asserted-by":"crossref","first-page":"31101","DOI":"10.1074\/jbc.M503763200","article-title":"The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity","volume":"280","author":"Basso","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T19:23:31Z","timestamp":1685474611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661810000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1043661810000642"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2010.02.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}